LSV Asset Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
Other funds holding UTMD
RHJA
CCMINC
EHC
RWM
AI
LSV Asset Management's UTMD Position: Q2 2026 in Review
LSV Asset Management reduced its Utah Medical Products (UTMD) stake by 9.6% in Q2 2026, selling an estimated $126K and leaving 17,959 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #647.
LSV Asset Management first reported a position in UTMD in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.32M in Q1 2023. 50 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.
- LSV Asset Management held 17,959 shares of Utah Medical Products worth $1.24M as of Q2 2026.
- LSV Asset Management sold 1,900 Utah Medical Products shares in Q2 2026, an estimated $126K.
- Utah Medical Products made up ﹤0.01% of LSV Asset Management's portfolio in Q2 2026, its #647 holding.
- LSV Asset Management first reported a position in Utah Medical Products in Q1 2022 and has held it in 18 quarters since.
- LSV Asset Management's Utah Medical Products position peaked at $2.32M in Q1 2023.
- 50 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.
Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.